200 related articles for article (PubMed ID: 26387541)
1. Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells.
Nitzki F; Cuvelier N; Dräger J; Schneider A; Braun T; Hahn H
Oncogene; 2016 Jun; 35(22):2923-31. PubMed ID: 26387541
[TBL] [Abstract][Full Text] [Related]
2. Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: a report from the Children's Oncology Group.
Pressey JG; Anderson JR; Crossman DK; Lynch JC; Barr FG
Pediatr Blood Cancer; 2011 Dec; 57(6):930-8. PubMed ID: 21618411
[TBL] [Abstract][Full Text] [Related]
3. Cyclopamine treatment of full-blown Hh/Ptch-associated RMS partially inhibits Hh/Ptch signaling, but not tumor growth.
Ecke I; Rosenberger A; Obenauer S; Dullin C; Aberger F; Kimmina S; Schweyer S; Hahn H
Mol Carcinog; 2008 May; 47(5):361-72. PubMed ID: 17963245
[TBL] [Abstract][Full Text] [Related]
4. Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma.
Zibat A; Missiaglia E; Rosenberger A; Pritchard-Jones K; Shipley J; Hahn H; Fulda S
Oncogene; 2010 Dec; 29(48):6323-30. PubMed ID: 20818440
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of mutant Ptch in rhabdomyosarcomas is associated with promoter hypomethylation and increased Gli1 and H3K4me3 occupancy.
Nitzki F; Tolosa EJ; Cuvelier N; Frommhold A; Salinas-Riester G; Johnsen SA; Fernandez-Zapico ME; Hahn H
Oncotarget; 2015 Apr; 6(11):9113-24. PubMed ID: 25823816
[TBL] [Abstract][Full Text] [Related]
6. Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice.
Nitzki F; Zibat A; Frommhold A; Schneider A; Schulz-Schaeffer W; Braun T; Hahn H
Oncogene; 2011 Oct; 30(43):4428-36. PubMed ID: 21602886
[TBL] [Abstract][Full Text] [Related]
7. Hedgehog-independent overexpression of transforming growth factor-beta1 in rhabdomyosarcoma of Patched1 mutant mice.
Eichenmüller M; Bauer R; Von Schweinitz D; Hahn H; Kappler R
Int J Oncol; 2007 Aug; 31(2):405-12. PubMed ID: 17611698
[TBL] [Abstract][Full Text] [Related]
8. Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors.
Drummond CJ; Hanna JA; Garcia MR; Devine DJ; Heyrana AJ; Finkelstein D; Rehg JE; Hatley ME
Cancer Cell; 2018 Jan; 33(1):108-124.e5. PubMed ID: 29316425
[TBL] [Abstract][Full Text] [Related]
9. Calcitriol inhibits hedgehog signaling and induces vitamin d receptor signaling and differentiation in the patched mouse model of embryonal rhabdomyosarcoma.
Uhmann A; Niemann H; Lammering B; Henkel C; Heß I; Rosenberger A; Dullin C; Schraepler A; Schulz-Schaeffer W; Hahn H
Sarcoma; 2012; 2012():357040. PubMed ID: 22550417
[TBL] [Abstract][Full Text] [Related]
10. PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma.
Hanna JA; Garcia MR; Go JC; Finkelstein D; Kodali K; Pagala V; Wang X; Peng J; Hatley ME
Cell Death Dis; 2016 Jun; 7(6):e2256. PubMed ID: 27277678
[TBL] [Abstract][Full Text] [Related]
11. Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma.
Kappler R; Bauer R; Calzada-Wack J; Rosemann M; Hemmerlein B; Hahn H
Oncogene; 2004 Nov; 23(54):8785-95. PubMed ID: 15480423
[TBL] [Abstract][Full Text] [Related]
12. Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma.
Hahn H; Wojnowski L; Specht K; Kappler R; Calzada-Wack J; Potter D; Zimmer A; Müller U; Samson E; Quintanilla-Martinez L; Zimmer A
J Biol Chem; 2000 Sep; 275(37):28341-4. PubMed ID: 10884376
[TBL] [Abstract][Full Text] [Related]
13. Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma.
Pomella S; Sreenivas P; Gryder BE; Wang L; Milewski D; Cassandri M; Baxi K; Hensch NR; Carcarino E; Song Y; Chou HC; Yohe ME; Stanton BZ; Amadio B; Caruana I; De Stefanis C; De Vito R; Locatelli F; Chen Y; Chen EY; Houghton P; Khan J; Rota R; Ignatius MS
Nat Commun; 2021 Jan; 12(1):192. PubMed ID: 33420019
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development.
Tostar U; Malm CJ; Meis-Kindblom JM; Kindblom LG; Toftgård R; Undén AB
J Pathol; 2006 Jan; 208(1):17-25. PubMed ID: 16294371
[TBL] [Abstract][Full Text] [Related]
15. Unbalanced overexpression of the mutant allele in murine Patched mutants.
Calzada-Wack J; Kappler R; Schnitzbauer U; Richter T; Nathrath M; Rosemann M; Wagner SN; Hein R; Hahn H
Carcinogenesis; 2002 May; 23(5):727-33. PubMed ID: 12016144
[TBL] [Abstract][Full Text] [Related]
16. Ligand-dependent Hedgehog pathway activation in Rhabdomyosarcoma: the oncogenic role of the ligands.
Almazán-Moga A; Zarzosa P; Molist C; Velasco P; Pyczek J; Simon-Keller K; Giralt I; Vidal I; Navarro N; Segura MF; Soriano A; Navarro S; Tirado OM; Ferreres JC; Santamaria A; Rota R; Hahn H; Sánchez de Toledo J; Roma J; Gallego S
Br J Cancer; 2017 Oct; 117(9):1314-1325. PubMed ID: 28881358
[TBL] [Abstract][Full Text] [Related]
17. LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcoma.
Dräger J; Simon-Keller K; Pukrop T; Klemm F; Wilting J; Sticht C; Dittmann K; Schulz M; Leuschner I; Marx A; Hahn H
Oncotarget; 2017 Jan; 8(2):3259-3273. PubMed ID: 27965462
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the PTCH coding region in human rhabdomyosarcoma.
Calzada-Wack J; Schnitzbauer U; Walch A; Wurster KH; Kappler R; Nathrath M; Hahn H
Hum Mutat; 2002 Sep; 20(3):233-4. PubMed ID: 12204003
[TBL] [Abstract][Full Text] [Related]
19. Time-point and dosage of gene inactivation determine the tumor spectrum in conditional Ptch knockouts.
Zibat A; Uhmann A; Nitzki F; Wijgerde M; Frommhold A; Heller T; Armstrong V; Wojnowski L; Quintanilla-Martinez L; Reifenberger J; Schulz-Schaeffer W; Hahn H
Carcinogenesis; 2009 Jun; 30(6):918-26. PubMed ID: 19321799
[TBL] [Abstract][Full Text] [Related]
20. Primary cilia control hedgehog signaling during muscle differentiation and are deregulated in rhabdomyosarcoma.
Fu W; Asp P; Canter B; Dynlacht BD
Proc Natl Acad Sci U S A; 2014 Jun; 111(25):9151-6. PubMed ID: 24927541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
